Swiss Nordic Bio Zürich 25 januari 2022
| Reference number | |
| Coordinator | Amplio Pharma AB |
| Funding from Vinnova | SEK 15 000 |
| Project duration | December 2021 - January 2022 |
| Status | Completed |
Important results from the project
Through the participation in the Swiss Nordic Bio meeting in Zurich on the 25th of January, a start up company like Amplio Pharma is given the chance to pitch itself and its pipeline to prospective investors and the industry. This increases the possibility of attracting the necessary funds for the company to continue its development.
Expected long term effects
Through the participation in the Swiss Nordic Bio meeting in Zurich on the 25th of January, we expect to increase our visibility to the industry and follow-up meetings with prospective investors.
Approach and implementation
The participation at the meeting by both the CEO and COO of Amplio Pharma AB included the travels there by plane (SEK 3400), hotel stay for 1 night (SEK 5600) and participation fees (8200), adding up to a total of SEK 17 200.